influenza
viru
iv
infect
repres
seriou
public
health
problem
present
establish
biomark
exist
support
diagnosi
respiratori
viral
infect
importantli
sever
iv
diseas
studi
anim
model
extrem
import
understand
biolog
genet
environment
factor
contribut
sever
iv
diseas
valid
biomark
candid
human
studi
howev
mous
human
crossspeci
comparison
often
compromis
fact
anim
studi
concentr
infect
lung
wherea
human
almost
studi
use
peripher
blood
patient
addit
human
studi
consid
genet
background
variabl
although
human
popul
genet
divers
therefor
studi
perform
crossspeci
gene
express
studi
peripher
blood
human
patient
highli
genet
divers
collabor
cross
cc
mous
popul
iv
infect
result
demonstr
chang
gene
express
individu
gene
highli
similar
mice
human
topregul
gene
human
also
differenti
regul
mice
conclud
mous
highli
valuabl
vivo
model
system
valid
discov
gene
candid
use
biomark
human
furthermor
mous
studi
allow
confirm
find
human
wellcontrol
experiment
system
ad
enorm
valu
understand
express
function
human
candid
gene
year
million
peopl
infect
worldwid
influenza
viru
iv
type
b
die
fauci
diagnosi
treatment
sever
iv
infect
import
determin
infect
statu
statu
time
qualiti
host
respons
detect
viru
nasal
swap
rapid
influenza
diagnost
test
polymeras
chain
reaction
test
first
step
diagnos
iv
infect
howev
detect
viru
per
se
swab
inform
treatment
decis
provid
inform
level
viru
replic
lung
relev
sever
iv
diseas
allow
clinician
evalu
degre
qualiti
host
respons
exampl
hypoxia
hallmark
sever
iv
infect
repres
late
stage
marker
diseas
therefor
signific
need
exist
earlier
biomark
prognost
valu
predict
develop
sever
iv
diseas
furthermor
whether
individu
suffer
viral
bacteri
pneumonia
import
implic
treatment
howev
often
difficult
differenti
two
type
pneumonia
use
current
diagnost
method
parnel
et
al
therefor
better
biomark
need
allow
diagnosi
diseas
driven
iv
infect
bacteri
coinfect
infectioninduc
host
respons
transcript
proteom
signatur
hold
promis
identifi
earli
prognost
biomark
use
predict
patient
outcom
iv
infect
other
perform
transcriptom
proteom
studi
identifi
virusspecif
signatur
ivinfect
patient
herberg
et
al
huang
et
al
ioannidi
et
al
marion
et
al
parnel
et
al
ramilo
et
al
suarez
et
al
tang
et
al
thach
et
al
tsalik
et
al
wood
et
al
zaa
et
al
zhai
et
al
urgent
need
valid
marker
understand
biolog
context
express
find
appli
clinic
howev
due
difficulti
associ
perform
mechanist
valid
studi
human
import
compar
find
wellcontrol
anim
model
result
human
mous
model
instrument
evalu
virul
pathogen
mechan
iv
infect
associ
host
respons
eg
kollmu
et
al
studi
genet
welldefin
mous
popul
shown
import
genet
background
suscept
resist
boon
et
al
ferri
et
al
leist
et
al
srivastava
et
al
trammel
et
al
particular
highli
genet
divers
collabor
cross
cc
genet
refer
popul
grp
repres
ideal
tool
studi
phenotyp
divers
caus
genotyp
variat
collabor
cross
consortium
cc
deriv
eight
genet
divers
founder
strain
intercross
inbr
produc
reproduc
popul
recombin
inbr
ri
strain
strain
genet
mosaic
origin
eight
founder
strain
collabor
cross
consortium
importantli
cc
strain
exhibit
million
singlenucleotid
polymorph
mani
insert
delet
structur
variat
compar
genet
divers
human
popul
collabor
cross
consortium
furthermor
divers
evenli
distribut
across
genom
cc
popul
level
addit
cc
repres
ideal
grp
map
quantit
trait
identifi
genet
variat
contribut
host
respons
iv
infect
may
highli
relev
sever
cours
iv
infect
human
collabor
cross
consortium
van
sluij
et
al
biomark
studi
human
mainli
limit
analysi
readili
avail
bodi
fluid
respiratori
infect
nasal
swab
blood
prefer
sourc
diagnosi
sever
infect
blood
prefer
nasal
swab
sinc
critic
infect
take
place
lung
therefor
almost
current
human
studi
analyz
blood
hand
almost
studi
mice
investig
infect
organ
lung
iv
aim
understand
biolog
mechan
site
infect
rais
import
caveat
comparison
respons
ivinfect
mous
lung
limit
valu
valid
biomark
identifi
human
peripher
blood
vice
versa
valu
extend
mous
studi
human
call
question
studi
compar
inflammatori
respons
burn
trauma
endotoxemia
mous
human
blood
seok
et
al
studi
receiv
signific
amount
attent
media
author
conclud
chang
transcriptom
observ
human
patient
could
replic
mice
howev
conclus
challeng
later
takao
miyakawa
also
import
note
seok
et
al
use
singl
inbr
mous
strain
model
human
sampl
came
patient
differ
genet
background
seok
et
al
therefor
truli
assess
whether
mous
model
use
identifi
valid
biomark
relev
human
infecti
diseas
import
care
compar
respons
appropri
tissu
case
blood
also
account
impact
host
genet
variat
furthermor
sinc
type
respons
like
specif
individu
pathogen
class
pathogen
also
import
extend
analysi
viral
pathogen
iv
analyz
peripher
blood
transcriptom
indic
host
respons
iv
infect
differ
cc
strain
compar
blood
transcriptom
chang
human
patient
infect
iv
show
global
respons
heterogen
mice
human
mous
model
genet
background
play
import
role
sever
iv
diseas
strongli
influenc
transcript
respons
furthermor
singl
gene
level
respons
mous
model
human
patient
similar
even
ident
conclus
result
support
use
experiment
mous
model
valid
find
human
iv
studi
suggest
addit
biomark
better
understand
biolog
environment
factor
drive
diseas
sever
transcript
respons
host
compar
host
transcriptom
respons
iv
infect
blood
human
patient
experiment
mous
model
sinc
human
genet
divers
also
chose
compar
respons
cc
due
high
level
genet
divers
present
genet
complex
mous
genet
refer
popul
studi
chose
eleven
cc
strain
time
readili
avail
resourc
univers
north
carolina
http
csbio
unceduccsta
tusindex
py
eleven
cc
strain
highli
inbr
residu
heterozygos
nine
carri
genom
region
eight
founder
strain
three
strain
contain
genom
region
six
founder
strain
togeth
eleven
strain
exhibit
good
represent
eight
founder
haplotyp
across
genom
fig
femal
cc
mice
n
age
week
infect
focu
form
unit
ffu
mouseadapt
viru
chang
bodi
weight
bw
surviv
follow
next
day
post
infect
pi
shown
fig
larg
variat
bw
loss
surviv
ratio
observ
across
strain
anova
reveal
signific
effect
strain
interact
strain
day
repeat
measur
use
data
day
day
mice
strain
still
aliv
model
bw
strain
day
broad
sens
herit
day
bw
valu
two
strain
resist
infect
infect
mice
surviv
fig
strain
exhibit
sever
phenotyp
infect
mice
die
refer
strain
sever
strain
manuscript
tabl
describ
cc
strain
suscept
categori
group
size
use
studi
result
demonstr
larg
genet
divers
cc
strain
result
highli
divers
iv
respons
phenotyp
also
reveal
suscept
resist
iv
infect
trait
strongli
influenc
genet
background
human
also
exhibit
high
level
variat
suscept
respons
infect
therefor
hypothes
major
part
variat
caus
genet
variat
set
cc
strain
better
repres
human
iv
infecti
diseas
studi
use
singl
inbr
mous
strain
base
variat
ivinduc
diseas
observ
cc
strain
compar
respons
iv
infect
mous
human
analyz
transcriptom
chang
whole
blood
infect
cc
strain
human
patient
collect
peripher
blood
infect
cc
mice
day
pi
perform
express
array
fig
highli
diverg
chang
bodi
weight
surviv
rate
cc
strain
infect
influenza
viru
eight
twelv
week
old
femal
mice
indic
cc
strain
infect
intranas
ffu
mouseadapt
influenza
viru
chang
bodi
weight
b
surviv
monitor
day
pi
mice
exhibit
weight
loss
rel
start
weight
euthan
score
dead
studi
experiment
set
import
crossspeci
comparison
sinc
studi
human
mainli
use
peripher
blood
found
chang
transcriptom
differ
lung
blood
fig
blood
data
studi
lung
data
taken
leist
et
al
exampl
mani
deg
observ
lung
compar
blood
like
due
fact
lung
primari
organ
infect
cell
composit
much
complex
lung
lung
tissu
plu
immun
cell
infiltr
blood
addit
mice
mock
infect
pb
serv
control
allow
us
exclud
influenc
infect
procedur
earli
time
point
infect
gene
express
chang
preuss
et
al
contrast
human
studi
patient
alreadi
symptomat
time
analysi
field
studi
result
compar
transcriptom
chang
peripher
blood
human
patient
data
set
download
public
databas
chose
three
public
avail
human
data
set
geo
gene
express
databas
http
wwwncbinlmnihgovgeo
first
studi
compos
human
volunt
infect
viru
wood
et
al
second
field
studi
compar
healthi
control
ivinfect
patient
zhai
et
al
third
data
set
deriv
studi
tang
et
al
data
set
chosen
public
avail
reason
larg
group
size
infect
patient
control
n
repres
studi
control
infect
human
volunt
analyz
current
largest
group
ivinfect
patient
n
depend
day
pi
data
set
follow
transcriptom
chang
time
compar
time
mous
data
day
pi
day
pi
furthermor
studi
identifi
one
strongli
upregul
gene
suggest
marker
iv
respiratori
viral
infect
tang
et
al
aim
compar
mous
human
host
respons
earli
time
point
infect
sinc
relev
diagnosi
treatment
decis
human
patient
risk
sever
infect
therefor
select
relev
time
point
day
pi
data
set
data
set
baselin
valu
infect
challeng
select
control
group
h
pi
day
h
pi
day
infect
group
also
select
sampl
infect
particip
show
symptom
data
set
name
select
sampl
deriv
ivinfect
patient
earli
time
point
infect
baselin
taken
prospect
enrol
occurr
symptom
valu
select
control
day
day
day
day
first
visit
within
h
occurr
symptom
infect
group
data
set
name
entir
data
set
use
name
tabl
provid
descript
data
set
use
studi
respect
time
point
group
size
tabl
list
sampl
first
perform
principl
compon
analysi
pca
control
infect
group
human
mous
compar
global
chang
gene
express
infect
analysi
perform
top
variant
probe
set
avoid
high
nois
low
level
express
transcript
infect
control
group
separ
pca
human
data
set
fig
b
c
well
mous
cc
strain
fig
howev
consider
overlap
infect
control
group
data
set
addit
clear
distinct
group
accord
day
picollect
data
set
human
factor
may
caus
overlap
resist
sever
sever
sever
resist
sever
sever
sever
infect
control
group
known
may
repres
differ
host
respons
vaccin
statu
infect
dose
comorbid
etc
howev
also
wellcontrol
mous
studi
overlap
infect
control
group
consider
mous
data
set
possibl
stratifi
group
respect
genet
background
stratif
show
differ
cc
strain
differ
larg
global
transcriptom
respons
iv
infect
fig
c
exampl
resist
strain
exhibit
hardli
chang
gene
express
respons
back
control
level
day
fig
hand
highli
suscept
cc
strain
exhibit
strong
overal
respons
infect
fig
pca
show
day
day
pi
respons
differ
larg
baselin
respons
strain
conclus
variat
host
respons
case
control
group
transcriptom
level
similarli
heterogen
mice
human
howev
wellcontrol
experiment
mous
model
larg
portion
variat
due
genet
divers
shown
genet
background
cc
strain
cc
founder
ferri
et
al
leist
et
al
strongli
influenc
viru
replic
lung
observ
mice
suggest
genet
variat
also
contribut
significantli
heterogen
suscept
host
respons
human
next
identifi
differenti
express
gene
deg
infect
control
group
human
mous
data
set
determin
overlap
within
speci
human
data
set
combin
variou
time
point
infect
singl
infect
group
contrast
healthi
control
infect
patient
mous
also
combin
differ
day
pi
singl
infect
group
mockinfect
anim
use
control
sinc
sever
case
death
human
perform
two
separ
comparison
cc
micebetween
infect
resist
strain
control
infect
sever
strain
control
differenti
express
gene
note
gene
repres
multipl
probe
set
analyz
separ
defin
exhibit
differ
express
valu
delta
log
infect
control
fals
discoveri
rate
use
bh
multipl
test
correct
fdr
base
outcom
infect
mice
distinguish
resist
sever
strain
see
tabl
show
number
differenti
express
probe
set
pairwis
comparison
infect
versu
control
detail
list
deg
found
supplementari
data
tabl
human
data
set
downregul
upregul
deg
found
invers
mous
comparison
also
mous
studi
mani
deg
detect
compar
human
reason
may
mous
experi
wellcontrol
therebi
less
prone
nois
uncontrol
confound
factor
human
determin
overlap
deg
comparison
fig
deg
human
data
set
deg
mous
resist
versu
control
fig
deg
human
data
set
deg
mous
sever
versu
control
deg
overlap
human
data
set
mous
resist
versu
control
deg
overlap
human
data
set
mous
sever
versu
control
deg
mani
overlap
deg
belong
interferon
pathway
activ
viral
infect
mous
human
data
set
uniqu
number
deg
share
group
uniqu
gene
enrich
particular
annot
across
data
set
use
r
packag
clusterprofil
yu
et
al
suggest
uniqu
differ
cohort
random
cc
share
annot
neutrophil
degranul
antigen
processingcross
present
uniqu
group
remark
set
uniqu
deg
cc
mice
specif
higher
compar
human
data
set
cc
uniqu
deg
divid
total
number
deg
fig
also
overlap
deg
cc
mice
deg
similarli
larg
overlap
deg
fig
base
result
conclud
global
level
differ
identif
deg
variou
human
studi
mainli
caus
differ
major
goal
human
studi
identifi
molecular
signatur
use
biomark
viral
versu
bacteri
infect
sever
versu
moder
infect
biomark
may
gene
chang
express
level
function
infect
yesno
pathogen
viralbacteri
diseas
sever
moderatesever
therefor
compar
chang
express
individu
gene
human
mous
determin
well
mous
model
mimic
human
respons
singl
gene
level
perform
compar
analysi
overlap
deg
fig
fig
human
data
set
combin
indic
day
pi
singl
infect
group
describ
mous
combin
resist
strain
singl
group
sever
strain
second
group
mocktreat
anim
use
control
differ
express
infect
healthi
control
human
signific
overlap
deg
similarli
differ
mice
sever
phenotyp
mock
control
signific
howev
gene
signific
differ
mice
resist
group
control
observ
mous
studi
wherea
differ
sever
group
control
significantli
differ
result
demonstr
singl
gene
level
result
mous
human
highli
compar
addit
mous
studi
reveal
differ
strain
exhibit
sever
influenza
diseas
versu
resist
strain
differ
repres
valuabl
candid
valid
human
sever
versu
moder
infect
outcom
thu
mous
wellsuit
model
human
respons
iv
infect
transcriptom
level
tissu
blood
speci
genet
variant
mous
popul
use
big
advantag
control
anim
infect
experi
possibl
studi
defin
time
point
infect
biolog
replic
includ
individu
sex
age
genet
background
human
studi
follow
natur
infect
variabl
often
control
best
time
onset
symptom
record
studi
wood
et
al
except
studi
analyz
blood
infect
volunt
h
infect
thu
one
wellcontrol
analys
respect
differ
time
point
pi
analysi
includ
time
point
h
data
set
sinc
later
time
point
sampl
singl
person
also
analyz
symptomat
patient
studi
zhai
et
al
record
also
tempor
chang
gene
express
case
sampl
collect
day
first
visit
within
h
occurr
symptom
day
first
visit
also
postseason
sampl
complet
recoveri
spring
zhai
data
set
includ
time
point
studi
pleas
note
human
data
set
larger
one
describ
tabl
sinc
contain
addit
time
point
exampl
perform
analysi
kinet
gene
express
chang
gene
human
mice
interferonregul
gene
propos
potenti
marker
distinguish
respiratori
viral
bacteri
infect
tang
et
al
top
deg
human
contrast
express
level
control
versu
infect
patient
three
human
data
set
studi
interferonregul
transcript
factor
import
host
gene
success
defens
iv
infect
mice
knockout
gene
suscept
iv
infect
hatesu
et
al
significantli
upregul
human
mous
blood
infect
studi
analys
show
human
express
steadili
increas
h
day
pi
h
day
pi
wood
data
set
reach
highest
level
h
fig
zhai
data
set
express
increas
day
day
declin
day
day
fig
express
level
back
baselin
level
day
postseason
fig
differ
time
two
dataset
due
differ
definit
time
post
infect
wood
count
actual
time
infect
wherea
zhai
design
day
patient
come
clinic
symptom
day
mice
individu
cc
strain
analyz
comparison
calcul
mean
differ
day
respect
mock
control
express
kinet
cc
mice
strain
similar
human
express
increas
day
pi
declin
day
pi
strain
fig
howev
individu
differ
differ
strain
could
observ
exampl
still
high
level
day
wherea
lower
level
alreadi
day
baselin
level
day
also
strain
exhibit
increas
express
day
day
visual
individu
express
valu
demonstr
gene
express
level
highli
reproduc
within
given
mous
strain
variat
due
experiment
variat
fig
note
baselin
level
mocktreat
alreadi
differ
cc
mous
strain
profil
differ
strain
although
gener
trend
ident
fig
result
mous
model
demonstr
genet
background
major
factor
caus
individu
differ
express
analys
show
similar
result
fig
upregul
earli
infect
increas
steadili
declin
later
time
point
immun
respons
mice
switch
innat
adapt
previous
describ
mice
pommerenk
et
al
mous
model
reproduc
well
gener
kinet
gene
express
observ
humanswith
differ
individu
strain
fig
fig
worth
note
wood
data
set
express
separ
two
differ
group
one
group
show
upregul
express
exhibit
upregul
although
volunt
infect
control
condit
reason
separ
unclear
experi
mice
approv
extern
committe
accord
nation
guidelin
anim
welfar
law
germani
bgbl
bgbl
protocol
use
experi
review
ethic
committe
approv
relev
author
landesamt
verbraucherschutz
und
lebensmittelsicherheit
oldenburg
germani
permit
number
ahong
origin
obtain
otto
haller
univers
freiburg
haller
et
al
virus
propag
chorioallanto
caviti
spf
specif
pathogenfre
embryon
chicken
egg
charl
river
laboratori
germani
h
describ
previous
aliquot
store
titer
stock
virus
determin
focu
form
unit
assay
ffuml
madindarbi
canin
kidney
ii
mdck
cell
atcc
describ
previous
viral
rna
extract
use
qiaamp
viral
rna
extract
kit
qiagen
accord
manufactur
instruct
submit
sequenc
nextgener
sequenc
illumina
valid
ident
viru
stock
cc
strain
obtain
system
genet
core
facil
univers
north
carolina
welsh
et
al
previou
reloc
unc
cc
line
gener
bred
tel
aviv
univers
israel
iraqi
et
al
geniad
australia
morahan
et
al
oak
ridg
nation
laboratori
us
chesler
et
al
mice
bred
anim
facil
hzi
braunschweig
brothersist
mate
one
eight
gener
depend
respect
strain
time
point
experi
experiment
mice
also
cousin
mate
perform
sinc
gener
breed
done
inbreed
statu
expect
similar
mice
receiv
unc
http
csbio
unc
educcsta
tusccgen
ome
genot
ype
mice
maintain
specif
pathogenfre
condit
accord
german
anim
welfar
law
femal
mice
anesthet
intraperiton
inject
ketaminexylazin
mgml
ketamin
mgml
xylazin
steril
sodium
chlorid
solut
dose
adjust
individu
bodi
weight
use
g
bodi
weight
mice
intranas
infect
viru
solut
ffu
bodi
weight
monitor
daili
percentag
initi
weight
day
infect
mice
lost
bodi
weight
euthan
ethic
reason
score
dead
blood
taken
rna
isol
differ
time
point
viru
infect
day
mock
infect
day
post
steril
phosphatebuff
salin
infect
bodi
weight
measur
day
sampl
collect
everi
treatment
day
post
infect
pi
mice
per
cc
strain
analyz
blood
collect
anesthet
mice
retroorbit
bleed
rna
protect
anim
blood
tube
qiagen
kept
room
temperatur
least
h
store
longterm
storag
blood
rna
isol
rneasi
protect
anim
blood
kit
qiagen
rna
concentr
measur
nanodrop
thermo
scientif
gene
express
profil
mous
gene
express
kit
agil
use
ng
total
rna
transcrib
cdna
amplifi
use
rna
polymeras
incorpor
cyanin
ctp
hybrid
accord
manufactur
protocol
quick
amp
agil
agil
k
mous
design
id
signal
intens
extract
scan
imag
use
featur
extract
softwar
array
data
mous
blood
sampl
analyz
use
r
softwar
rcoreteam
preprocess
step
includ
background
correct
quantil
normal
annot
use
carlson
limma
smyth
gentleman
et
al
packag
identif
differenti
express
probe
set
dep
perform
limma
packag
smyth
use
bh
correct
multipl
test
benjamini
hochberg
express
data
deposit
geo
express
databas
http
wwwncbinlmnihgovgeoinfolinki
nghtml
access
number
follow
human
data
download
geo
express
data
base
http
wwwncbinlmnihgov
geo
tang
et
al
wood
et
al
zhai
et
al
express
data
matrix
log
transform
quantil
normal
data
volunt
symptom
infect
use
wood
et
al
data
set
contain
express
valu
blood
volunt
time
point
includ
baselin
prechalleng
data
h
time
point
pi
contain
data
volunt
omit
express
data
matrix
contain
log
transform
valu
download
geo
quantil
normal
data
influenzainfect
patient
use
zhai
et
al
data
set
contain
express
valu
blood
patient
time
point
includ
baselin
prechalleng
data
express
data
log
transform
quantil
normal
describ
tang
et
al
data
set
contain
express
valu
blood
patient
time
point
pi
describ
result
section
tabl
subset
relev
studi
use
renam
respect
describ
tabl
data
analyz
use
graphpad
prism
version
window
graphpad
softwar
san
diego
california
mean
standard
error
mean
sem
calcul
group
analysi
varianc
anova
perform
use
lm
aov
function
r
softwar
packag
rcoreteam
repeat
measur
anova
perform
use
model
weight
loss
strain
day
day
day
mice
strain
still
aliv
broad
sens
herit
determin
calcul
interclass
correl
rutledg
et
al
msb
msw
msb
n
msw
msb
mean
squar
group
msw
mean
squar
within
group
n
mean
number
mice
per
strain
function
analysi
gene
group
perform
r
packag
clusterprofil
yu
et
al
season
iv
infect
repres
signific
public
health
burden
estim
million
case
influenza
infect
occur
global
year
fauci
illustr
fact
unit
state
approxim
ivassoci
hospit
ivassoci
death
year
associ
medic
cost
excess
billion
dollar
youngxu
et
al
therefor
given
larg
number
ivassoci
hospit
signific
health
consequ
sever
ivassoci
diseas
new
method
need
rapidli
assess
individu
prognosi
appropri
treatment
regimen
initi
time
manner
ensur
better
clinic
outcom
transcript
zhai
et
al
c
histogram
repres
differ
express
chang
infect
mice
indic
time
pi
minu
mock
control
valu
cc
mous
strain
strain
sort
resist
sever
group
proteom
analysi
readili
avail
clinic
sampl
peripher
blood
repres
promis
avenu
identifi
prognost
biomark
use
predict
patient
outcom
iv
infect
herberg
et
al
huang
et
al
ioannidi
et
al
marion
et
al
parnel
et
al
ramilo
et
al
suarez
et
al
tang
et
al
thach
et
al
tsalik
et
al
wood
et
al
zaa
et
al
zhai
et
al
due
difficulti
associ
perform
followup
studi
fig
time
cours
gene
express
chang
human
mous
data
set
express
valu
normal
log
transform
signal
intens
blood
human
mice
infect
individu
versu
control
shown
indic
time
pi
stripchart
individu
express
valu
wood
et
al
b
zhai
et
al
c
histogram
repres
differ
express
chang
infect
mice
indic
time
pi
minu
mock
control
valu
cc
mous
strain
strain
sort
resist
sever
group
human
valid
mechanist
evalu
biosignatur
often
reli
anim
model
iv
diseas
howev
valu
experiment
model
especi
mous
recent
question
scientif
literatur
public
seok
et
al
result
challeng
later
takao
miyakawa
address
two
import
aspect
often
ignor
crossspeci
mousehuman
comparison
influenc
genet
background
choic
correct
tissu
result
clearli
demonstr
compar
appropri
tissu
type
peripher
blood
account
impact
genet
variat
ivassoci
gene
express
use
genet
complex
mous
panel
biosignatur
identifi
mous
show
good
concord
human
studi
therefor
experiment
anim
system
repres
import
set
tool
identif
mechanist
analysi
andor
valid
biosignatur
ivinduc
diseas
iv
infect
inbr
mous
strain
repres
one
commonli
use
system
studi
iv
diseas
pathogenesi
identifi
host
factor
associ
virusinduc
diseas
outcom
kollmu
et
al
due
wide
rang
factor
includ
reproduc
standard
inbr
strain
mice
abil
studi
role
specif
gene
iv
diseas
pathogenesi
gene
knockout
anim
avail
extens
toolkit
reagent
quantifi
immun
host
respons
mous
howev
note
mous
model
recent
come
attack
due
question
whether
mous
reproduc
diseas
state
gene
express
profil
observ
human
seok
et
al
studi
seok
et
al
rais
concern
mous
model
import
note
studi
account
impact
genet
divers
differenti
find
mice
human
therefor
find
studi
popul
genet
divers
mous
strain
cc
result
ivinduc
transcript
signatur
better
reproduc
human
biomark
import
implic
iv
also
studi
pathogen
similar
cc
founder
ferri
et
al
leist
et
al
cc
mice
exhibit
broad
rang
phenotyp
follow
infect
pathogen
gralinski
et
al
rasmussen
et
al
suggest
use
cc
identifi
biosignatur
pathogen
may
also
provid
greater
concord
human
studi
seen
exist
mous
model
anoth
import
aspect
studi
direct
comparison
transcript
respons
peripher
blood
mice
human
analysi
ivinduc
respons
lung
peripher
blood
suggest
gene
express
pattern
kinet
differ
tissu
addit
effect
genet
divers
discuss
like
contribut
discord
mous
human
gene
express
studi
therefor
import
directli
compar
tissu
mice
human
perform
marker
valid
studi
furthermor
result
illustr
import
perform
care
control
gene
express
studi
mice
sinc
abil
assess
baselin
gene
express
mockinfect
anim
provid
opportun
specif
identifi
gene
differenti
express
due
iv
infect
studi
address
import
public
health
issu
sinc
good
biomark
distinguish
bacteri
viral
respiratori
infect
predict
sever
cours
influenza
diseas
thu
transcript
chang
mice
may
repres
potenti
biomark
need
valid
human
therefor
use
appropri
divers
mous
model
combin
assess
gene
express
differ
appropri
tissu
type
eg
peripher
blood
provid
excel
system
identifi
confirm
biolog
relev
biomark
differenti
iv
versu
infect
predict
iv
diseas
outcom
analysi
mousehuman
transcriptom
chang
peripher
blood
demonstr
mous
repres
highli
valuabl
model
valid
discoveri
chang
singl
gene
human
patient
level
singl
gene
mous
model
well
reproduc
respons
observ
human
cohort
differenti
express
infect
noninfect
group
respect
time
cours
express
upregul
iv
infect
mice
human
gene
therefor
repres
good
biomark
candid
respiratori
viral
infect
inde
alreadi
follow
aspect
confirm
independ
cohort
human
shown
dendrit
cell
dc
activ
express
exposur
iv
summari
gene
express
chang
singl
gene
level
demonstr
high
reproduc
across
speci
thu
result
human
valid
mice
vice
versa
therefor
welldesign
crossspeci
studi
highli
inform
opinion
essenti
develop
better
treatment
diagnosi
human
